1. Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate‐ but not mycophenolate‐ or post‐transplant cyclophosphamide‐based graft versus host disease prophylaxis. (28th March 2023) Authors: Nikoloudis, A.; Buxhofer‐Ausch, V.; Aichinger, C.; Binder, M.; Hasengruber, P.; Kaynak, E.; Wipplinger, D.; Milanov, R.; Strassl, I.; Stiefel, O.; Machherndl‐Spandl, S.; Petzer, A.; Weltermann, A.; Clausen, J. Journal: European journal of haematology Issue: Volume 110:Number 6(2023) Page Start: 715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗